bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

CyPath® Lung in Practice: From Uncertainty to Clarity and Confidence

by Maria Zannes | Dec 2, 2025 | Publications

American Cancer Society National Lung Cancer Roundtable, December 7, 2025 Author: Gordon Downie, MD, PhD, bioAffinity Technologies Chief Medical Officer.   Three patient case studies in which CyPath® Lung, a noninvasive sputum-based flow cytometry test,...

Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result

by Maria Zannes | Sep 18, 2024 | Publications

Journal of Health Economics and Outcomes Research, September 17, 2024 Authors: Morris M.J., Habib S.A., Do Valle M.L., Schneider J.E. Abstract Background: Early detection of lung cancer is crucial for improving patient outcomes. Although advances in diagnostic...

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

by Maria Zannes | Mar 24, 2023 | Publications

JoVE Journal, March 24, 2023 Authors William Bauta, Marcia Grayson, Rossella Titone, Jennifer Rebeles, Vivienne I. Rebel Abstract Flow cytometry can rapidly characterize and quantify diverse cell populations based on fluorescence measurements. The cells are first...

Reassessing Cobalamin Requirements in Cell Culture

by Maria Zannes | Dec 1, 2022 | Publications

Cell Bio, a joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), in Washington, D.C., on Dec. 3-7, 2022. AuthorsDavid J. Elzi, Reggie Jacob, and Vivienne I. Rebel Introduction Cobalamin (Vitamin B12) is an...

Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

by Maria Zannes | Aug 17, 2022 | Publications

“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022   Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al.   Abstract Low-dose computed tomography...
« Older Entries

Categories

  • Articles (28)
  • Events (38)
  • News (53)
  • Press Releases (151)
  • Publications (18)

Recent Posts

  • bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable December 3, 2025
  • CyPath® Lung in Practice: From Uncertainty to Clarity and Confidence December 2, 2025
  • bioAffinity Technologies Reports Third Quarter 2025 Financial Results November 14, 2025
  • bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume November 5, 2025
  • bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases October 28, 2025
CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.